Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001680367-22-000015
Filing Date
2022-05-12
Accepted
2022-05-12 06:03:30
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sttk-20220331.htm   iXBRL 10-Q 762045
2 EX-31.1 sub-certxsection302xceoxq1.htm EX-31.1 17371
3 EX-31.2 sub-certxsection302xcfoxq1.htm EX-31.2 17311
4 EX-32.1 sub-certxsection906ofthesa.htm EX-32.1 9261
  Complete submission text file 0001680367-22-000015.txt   4133276

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20220331.xsd EX-101.SCH 26825
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sttk-20220331_cal.xml EX-101.CAL 50959
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sttk-20220331_def.xml EX-101.DEF 96148
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20220331_lab.xml EX-101.LAB 396910
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20220331_pre.xml EX-101.PRE 246178
46 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20220331_htm.xml XML 637249
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39593 | Film No.: 22915527
SIC: 2834 Pharmaceutical Preparations